Acutus Medical logo

Acutus MedicalNASDAQ: AFIB

Profile

Sector:

Healthcare

Country:

United States

IPO:

06 August 2020

Next earnings report:

01 April 2025

Last dividends:

N/A

Next dividends:

N/A
$1.79 M
-98%vs. 3y high
5%vs. sector
-vs. 3y high
-vs. sector
-116%vs. 3y high
14%vs. sector
-99%vs. 3y high
5%vs. sector

Price

regular market | Wed, 20 Nov 2024 19:46:43 GMT
$0.06-$0.01(-9.09%)

Dividend

No data over the past 3 years
$5.27 M-$5.61 M

Analysts recommendations

Institutional Ownership

AFIB Latest News

Acutus Medical Reports Second Quarter and Year-To-Date 2024 Financial Results
globenewswire.com08 August 2024 Sentiment: NEUTRAL

CARLSBAD, Calif., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (OTC: AFIB) today reported results for the second quarter and year-to-date of 2024.

Top 4 Health Care Stocks That Could Blast Off This Quarter - Acutus Medical (NASDAQ:AFIB), Becton Dickinson (NYSE:BDX)
Benzinga17 November 2023 Sentiment: POSITIVE

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Acutus Medical to Cancel Third Quarter 2023 Conference Call
GlobeNewsWire10 November 2023 Sentiment: NEGATIVE

CARLSBAD, Calif., Nov. 10, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), today announced that, following the Company's announcement of its strategic realignment of resources and corporate restructuring and release of its third quarter results on November 8, 2023, the Company will no longer hold its third quarter results conference call and webcast which was previously scheduled for Monday, November 13, 2023.

Acutus Medical to Announce Third Quarter 2023 Financial Results
GlobeNewsWire02 November 2023 Sentiment: NEGATIVE

CARLSBAD, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced today that it will release its third quarter 2023 financial results on Monday, November 13, 2023. In conjunction with the release, Acutus will host a conference call and webcast that day at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results and recent highlights.

Acutus Medical, Inc. (AFIB) Q2 2023 Earnings Call Transcript
Seeking Alpha07 August 2023 Sentiment: POSITIVE

Acutus Medical, Inc. (NASDAQ:AFIB ) Q2 2023 Earnings Conference Call August 7, 2023 4:30 AM ET Company Participants Caroline Corner - IR David Roman - CEO Takeo Mukai - CFO Conference Call Participants Marie Thibault - BTIG John Young - Canaccord Genuity Margaret Kaczor - William Blair Operator Good day, and thank you for standing by, and welcome to the Acutus Medical Second Quarter 2023 Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded.

Acutus Medical, Inc. (AFIB) Reports Q2 Loss, Tops Revenue Estimates
Zacks Investment Research07 August 2023 Sentiment: POSITIVE

Acutus Medical, Inc. (AFIB) came out with a quarterly loss of $0.63 per share versus the Zacks Consensus Estimate of a loss of $0.61. This compares to earnings of $0.16 per share a year ago.

Acutus Medical, Inc. (AFIB) Q1 2023 Earnings Call Transcript
Seeking Alpha11 May 2023 Sentiment: POSITIVE

Acutus Medical, Inc. (NASDAQ:AFIB ) Q1 2023 Earnings Conference Call May 11, 2023 4:30 PM ET Company Participants Caroline Corner - Investor Relations David Roman - President & Chief Executive Officer Takeo Mukai - Vice President of Finance & Accounting, Interim Chief Financial Officer Conference Call Participants John Young - BTIG Marie Thibault - BTIG Operator Good afternoon and thank you for standing by. Welcome to the Acutus Medical First Quarter 2023 Conference Call.

Acutus Medical to Announce First Quarter 2023 Financial Results
GlobeNewsWire28 April 2023 Sentiment: NEGATIVE

CARLSBAD, Calif., April 28, 2023 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced today that it will release its first quarter 2023 financial results on Thursday, May 11, 2023. In conjunction with the release, Acutus will host a conference call and webcast that day at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results and recent highlights.

What type of business is Acutus Medical?

Acutus Medical, Inc. designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.

What sector is Acutus Medical in?

Acutus Medical is in the Healthcare sector

What industry is Acutus Medical in?

Acutus Medical is in the Medical Devices industry

What country is Acutus Medical from?

Acutus Medical is headquartered in United States

When did Acutus Medical go public?

Acutus Medical initial public offering (IPO) was on 06 August 2020

What is Acutus Medical website?

https://www.acutusmedical.com

Is Acutus Medical in the S&P 500?

No, Acutus Medical is not included in the S&P 500 index

Is Acutus Medical in the NASDAQ 100?

No, Acutus Medical is not included in the NASDAQ 100 index

Is Acutus Medical in the Dow Jones?

No, Acutus Medical is not included in the Dow Jones index

When was Acutus Medical the previous earnings report?

No data

When does Acutus Medical earnings report?

The next expected earnings date for Acutus Medical is 01 April 2025